OCT 30, 2026 · REVIEW
EMERGING PHARMACOLOGICAL STRATEGIES IN OBESITY: FROM GLP-1 AGONISTS THROUGH TRIPLE INCRETIN THERAPY TO AMYLIN ANALOGS – NARRATIVE REVIEW
Archiv Euromedica
Background Obesity is one of the most prevalent chronic diseases and a growing public health burden, resulting from complex interactions between genetic, environmental, and neuroen